Muscle relaxation is a core component of anaesthesia which helps facilitate endotracheal intubation and provides optimal surgical operating conditions.

Anaesthetists have access to a wide variety of Neuromuscular blocking agents (NMBAs) for this purpose. Following surgery, relaxation is no longer needed, hence it is important that effects of the NMBAs be quickly and effectively terminated. Residual neuromuscular blockade after surgery has been associated with adverse patient outcomes including airway obstruction, hypoxia, respiratory complications, and symptoms of muscle weakness and dyspnea. The use of neuromuscular blockade, especially without reversal, has been associated with an increased risk of postoperative pneumonia.

Cath lab procedures like percutaneous trans-catheter device closure procedures are nowadays a routine treatment of cardiac lesions like septal defects, ruptured sinus of valsalva .Most of these procedures are done under general anaesthesia with the muscle relaxation and maintenance with inhalational agents like sevoflurane to ensure precision of catheter movements during procedures. The duration of action of NMBs in this group of patients are prolonged because of low ambient temperature and altered cardiovascular physiology and there is an added risk of recurarization in these patients after reversal and shifting to PACU. Hence this represents a group of patients where quick and effective reversal at the end of the procedure can facilitate earlier extubation and reduced post operative pulmonary complications.The added advantages of reduced ICU stay becomes very relevant in our Cath lab which has a very high turnover rate. Hence Sugammadex if proven to be quicker in onset and more effective can replace the current reversal agent Neostigmine thus helping in faster reversal of neuromuscular blockade and better patient care.